Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 332,314 | 116,334 | 75,475 | 78,447 | 227,547 |
| Cost of Goods | 68,601 | 43,267 | 26,967 | 14,217 | 2,392 |
| Gross Profit | 263,713 | 73,067 | 48,508 | 64,230 | 225,155 |
| Operating Expenses | 209,912 | 228,897 | 228,976 | 291,177 | 346,943 |
| Operating Income | 54,402 | -155,563 | -179,501 | -226,730 | -121,396 |
| Interest Expense | 59,251 | 58,976 | 56,810 | 46,353 | 22,670 |
| Other Income | -46,896 | 5,291 | 2,652 | 3,975 | 515 |
| Pre-tax Income | -51,745 | -209,248 | -233,659 | -269,108 | -143,551 |
| Net Income Continuous | -51,745 | -209,248 | -233,659 | -269,108 | -143,551 |
| Net Income | $-51,745 | $-209,248 | $-233,659 | $-269,108 | $-143,551 |
| EPS Basic Total Ops | -0.28 | -2.03 | -3.52 | -9.31 | -5.23 |
| EPS Basic Continuous Ops | -0.28 | -2.03 | -3.52 | -9.31 | -5.23 |
| EPS Diluted Total Ops | -0.28 | -2.03 | -3.52 | -9.31 | -5.23 |
| EPS Diluted Continuous Ops | -0.28 | -2.03 | -3.52 | -9.31 | -5.23 |
| EPS Diluted Before Non-Recurring Items | 0.01 | -2.03 | -3.52 | -9.31 | -5.23 |
| EBITDA(a) | $55,963 | $-154,114 | $-177,101 | $-224,485 | $-119,205 |